Home / Poland / Pknorlen
Pknorlen No short position is open on this share today.
Follow
0.00% of the capital sold short
0 disclosing funds
122 disclosures on record
Evolution of the disclosed total 0% 1%
Oct 2025 Jan 2026 Apr 2026 Jul 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up. The whole history, peaking at 5.92% on October 5, 2015. The shaded band is the year shown above. November 2, 2012 today
Open positions No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
Follow by RSS
Get the moves on Pknorlen by mail.
No account: one address, one link to confirm, one link to stop in every message.
History of disclosures 122 disclosures on record for this share. Date Fund % of capital End of publication February 22, 2021 Marshall Wace LLP 0.00% February 8, 2021 Marshall Wace LLP 0.57% January 26, 2021 Marshall Wace LLP 0.60% January 14, 2021 Marshall Wace LLP 0.50% December 23, 2020 Marshall Wace LLP 0.00% December 3, 2020 Marshall Wace LLP 0.51% December 2, 2020 Marshall Wace LLP 0.00% November 9, 2020 Marshall Wace LLP 0.51% July 24, 2017 Carlson Capital UK LLP 0.00% June 20, 2017 Blue Ridge Capital LLC 0.00% June 16, 2017 Blue Ridge Capital LLC 0.56% June 13, 2017 Blue Ridge Capital LLC 0.67% June 12, 2017 Blue Ridge Capital LLC 0.75% June 8, 2017 Carlson Capital UK LLP 0.59% May 16, 2017 Carlson Capital UK LLP 0.66% May 11, 2017 Blue Ridge Capital LLC 0.84% May 9, 2017 Blue Ridge Capital LLC 0.96% May 5, 2017 Blue Ridge Capital LLC 1.16% April 10, 2017 Bluemountain Capital Management, LLC 0.00% March 29, 2017 Bluemountain Capital Management, LLC 0.59% March 17, 2017 Carlson Capital UK LLP 0.70% March 9, 2017 Lone Pine Capital LLC 0.00% February 24, 2017 Lone Pine Capital LLC 0.58% February 16, 2017 Carlson Capital UK LLP 0.60% February 14, 2017 Blue Ridge Capital LLC 1.38% December 19, 2016 Blue Ridge Capital LLC 1.47% December 8, 2016 Carlson Capital UK LLP 0.51% October 11, 2016 Blackrock Investment Management (UK) Limited 0.00% October 4, 2016 Bluemountain Capital Management, LLC 0.69% May 17, 2016 Blackrock Investment Management (UK) Limited 0.59% April 19, 2016 Blackrock Investment Management (UK) Limited 0.66% April 7, 2016 Blackrock Investment Management (UK) Limited 0.70% April 5, 2016 Bluemountain Capital Management, LLC 0.76% February 4, 2016 Blackrock Investment Management (UK) Limited 0.61% January 7, 2016 Bluemountain Capital Management, LLC 0.80% December 16, 2015 TWO Creeks Capital Management, LP 0.00% December 11, 2015 TWO Creeks Capital Management, LP 0.57% December 9, 2015 TWO Creeks Capital Management, LP 0.62% December 8, 2015 TWO Creeks Capital Management, LP 0.72% November 16, 2015 TWO Creeks Capital Management, LP 0.89% November 12, 2015 TWO Creeks Capital Management, LP 0.94% November 10, 2015 TWO Creeks Capital Management, LP 1.02% November 9, 2015 Lone Pine Capital LLC 0.63% November 9, 2015 Blackrock Investment Management (UK) Limited 0.59% November 4, 2015 Lone Pine Capital LLC 0.55% November 3, 2015 Hound Partners, LLC 0.00% October 28, 2015 Blackrock Investment Management (UK) Limited 0.63% October 28, 2015 Hound Partners, LLC 0.50% October 21, 2015 Hound Partners, LLC 0.67% October 13, 2015 Hound Partners, LLC 0.79%
Download 122 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Page 1 of 3
Other companies sold short in Poland Modivo 4.94% of the capital sold short Grupaazoty 1.79% of the capital sold short Crquantum 1.69% of the capital sold short Budimex 1.30% of the capital sold short JSW 1.29% of the capital sold short Cdprojekt 1.12% of the capital sold short Dinopl 1.12% of the capital sold short Allegro 0.93% of the capital sold short Kety 0.89% of the capital sold short Scanway 0.60% of the capital sold short Kruk 0.52% of the capital sold short Cite this page The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Pknorlen, source KNF, data as at February 22, 2021, https://www.quivad.com/action/pknorlen